News

If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...
Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.
The goal with ProKidney Corp.'s rilparencel-branded therapy is "to demonstrate the therapy's potential to preserve kidney function in patients with advanced chronic kidney disease and diabetes." ...
Imugene is tapping the market for up to $35 million, while Clever Culture Systems and Compumedics are soaring on positive ...
An Ozempic user has revealed what they believe is a 'terrifying' side effect of upping their Ozempic dose. Falling into the category of GLP-1 medications, Ozempic is FDA-approved for type two diabetes ...
A new report says the prevalence of obesity increased faster during the COVID-19 pandemic than it did over the course of more ...
Explore the growing GLP-1 agonists market, driven by rising diabetes and obesity rates. Discover advancements in therapies like Tirzepatide and GZR18 ...
The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the start.
This year, drug companies have been living under a cloud of uncertainty created by the Trump administration. Threats of tough ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.
B.C. Emergency Health Services is seeing an uptick in life-threatening allergic reactions during the summer months. They say the right care and quick thinking can help avoid that. CBC's Tanushi ...